GO Therapeutics, Inc.
7Patents
7Active
7Granted
49Portfolio score
Filing activity: Nov 5, 2010 → Sep 29, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9588121B2 | Method for early detection of cancer | Chemistry; Metallurgy | 4 | Active |
| US11161911B2 | Anti-glyco-MUC1 antibodies and their uses | Physics | 2 | Active |
| US10139414B2 | Tn-MUC4 binding polypeptides and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11067578B2 | Tn-MUC4 binding polypeptides and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12269892B2 | Anti-glyco-MUC1 antibodies and their uses | Chemistry; Metallurgy | 0 | Active |
| US11860165B2 | CORE3-MUC1 binding polypeptides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12065504B2 | Anti-glyco-MUC1 antibodies and their uses | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.